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	 Simultaneous	 quantification	 of	 levonorgestrel	 (LEV)	 and	 ethinyl	 estradiol	 (EE)	 was
performed	utilizing	five	different	spectrophotometric	methods	and	a	high	performance	thin
layer	 chromatographic	 method	 (HPTLC).	 The	 applied	 spectrophotometric	 methods	 were
based	on	either	ratio	spectra	namely;	ratio	difference,	ratio	subtraction	and	derivative	ratio
or	 the	 presence	 of	 isosbestic	 point	 specifically;	 absorbance	 subtraction	 and	 amplitude
modulation.	The	proposed	methods	had	the	ability	to	resolve	the	overlapped	spectra	of	the
drugs	with	a	linear	relationship	in	the	concentration	range	1‐65	µg/mL	and	1‐95	µg/mL	for
LEV	and	EE,	respectively.	The	developed	HPTLC	method	has	revealed	a	good	separation	of
the	 drugs	 upon	 utilizing	 Nano	 Silica	 Gel	 on	 TLC	 plates	with	 fluorescent	 indicator	 254	 nm
glass	plates	as	the	stationary	phase	and	chloroform:	methanol	(99:1,	v:v)	as	the	mobile	phase.
The	proposed	HPTLC	method	has	shown	high	sensitivity,	where	the	linearity	range	was	0.02‐
3.00	 µg/band	 and	 0.5‐20.0	 µg/band,	 for	 LEV	 and	 EE,	 respectively.	 The	 proposed	methods
were	 successfully	 applied	 for	 the	 analysis	 of	 laboratory	 prepared	 mixtures	 as	 well	 as
combined	dosage	form.	Validation	for	all	methods	was	conducted	in	compliance	with	the	ICH
guidelines	proving	 the	methods	 to	be	 selective,	 linear,	 precise	 and	accurate.	The	proposed
methods	were	statistically	compared	with	the	pharmacopoeial	method,	where	the	obtained
results	showed	no	significant	difference	regarding	accuracy	and	precision.	
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1.	Introduction	
	
Levonorgestrel	 ((8R,9S,10R,13S,14S,17R)‐13‐ethyl‐17‐
ethynyl‐17‐hydroxy‐1,2,6,7,8,9,10,11,12,14,15,16‐dodeca	
hydrocyclopenta[a]phenanthren‐3‐one)	 (Figure	 1a)	 is	 a	
synthetic	 female	 hormone	which	 is	 usually	 administered	 for	
pregnancy	 prevention	 in	 humans	 [1].	 Ethinyl	 estradiol;	
((8R,9S,13S,14S,17R)‐17‐ethynyl‐13‐methyl‐7,8,9,11,12,14,15,	
16‐octahydro‐6H‐cyclopenta[a]phenanthrene‐3,17‐diol)	
(Figure	1b)	 is	 an	orally	 bioactive	 estrogen	usually	 present	 in	
many	combined	 formulations	of	 	oral	contraceptive	pills.	 It	 is	
mainly	utilized	in	hormone	therapies	for	androgen	dependent	
disorders,	acne,	hirsutism	and	seborrhoea	[2].	
Recently,	 it	was	 shown	 that,	 the	 continuous	daily	LEV‐EE	
dose	of	(150‐30	μg)	suppresses	ovarian	activity	and	eliminates	
cyclic	 fluctuations	 in	 estradiol	 [3],	 progesterone,	 luteinizing	
hormone	and	follicle‐stimulating	hormone	[4].	In	addition,	the	
combination	of	these	drugs	was	used	as	an	oral	contraceptive	
for	 female	 patients	 with	 androgenic	 symptoms	 [5].	 Many	
brands	 and	 generic	 combinations	 of	 these	 compounds	 were	
released	in	the	pharmaceutical	market	[6].	Microcept®	coated	
tablets	 (the	 Egyptian	 trade	 name);	 containing	 LEV	 and	 EE	 is	
widely	used	as	a	contraceptive	and	 for	 the	reduction	of	post‐
menopausal	symptoms	[7].	Therefore,	the	analysis	of	the	drugs	
in	these	pharmaceutical	formulations	is	quite	important	and	is	
a	common	analytical	problem	in	quality	control	industry.	
	
(a)	
	
(b)	
Figure	1.	Molecular	 structures	of	 (a)	 levonorgestrel	 (LEV)	and	 (b)	ethinyl	
estradiol	(EE).	
Rizk	et	al.	/	European	Journal	of	Chemistry	8	(1)	(2017)	52‐59	 53	
 
Literature	 survey	 has	 revealed	 several	 analytical	
techniques	for	the	simultaneous	analysis	of	the	studied	drugs.	
This	 combination	 is	 official	 in	 United	 States	 Pharmacopoeia	
(USP),	 which	 describes	 a	 chromatographic	 method	 for	 its	
estimation	 [8].	 In	 addition,	 RP‐HPLC	 [9],	 HPLC‐tandem	mass	
spectrometry	 [10,11],	 molecular	 imprinted	 polymer‐HPLC	
[12],	 immune‐affinity	 chromatography	 [13],	 HPTLC	 [14‐15],	
micellar	electrokinetic	 chromatography	 (MEKC)	 [16],	voltam‐
metry	 [17],	multivariate	 calibration	 technique	of	partial	 least	
squares	(PLS)	and	principal	component	regression	(PCR)	[18],	
first	 derivative	 spectrophotometry	 [19,20]	 and	 H‐Point	
standard	addition	spectrophotometry	[21‐23]	were	developed	
for	 the	 determination	 of	 LEV	 and	 EE	 in	 biological	 and	
pharmaceutical	matrixes.	It	is	obvious	that	most	of	the	repor‐
ted	methods	for	the	determination	of	LEV	and	EE	have	utilized	
hyphenated	 instrumentation	 whose	 use	 is	 considered	 a	
tedious	 process.	 These	 hyphenated	 analytical	 techniques	 are	
considered	 time	 consuming	 and	 require	 high	 cost	 as	 they	
usually	involve	several	separation	steps	with	the	utilization	of	
complex	 components.	 On	 the	 contrary	 are	 the	 mathematical	
spectrophotometric	 and	 chemometric	 techniques	which	 have	
the	ability	to	overcome	the	above	drawbacks	in	addition	they	
can	efficiently	resolve	complex	mixtures	of	analytes.	However,	
chemometric	techniques	are	less	advantageous	as	they	require	
the	 availability	 of	 specific	 software	 for	 performing	 the	
manipulation	steps	[24,25].		
Although	LEV/EE	is	an	old	combination	and	is	released	in	
the	 market	 long	 time	 ago,	 however,	 few	 spectrophotometric	
methods	 were	 described	 in	 the	 literature	 for	 the	 analysis	 of	
this	 combination.	The	 reported	 first	 derivative	 spectrophoto‐
metric	methods	[19,20]	have	shown	the	disadvantage	that	the	
zero	crossing	point	of	EE	at	λ	249	nm	does	not	correspond	to	a	
peak	maximum	 or	 valley	 for	 LEV	which	 affects	 the	 accuracy	
and	 sensitivity	 of	 the	 methods.	 While	 the	 reported	 H‐point	
standard	 addition	 methods	 [21‐23]	 had	 the	 disadvantage	 of	
several	 calculation	 steps	 which	 could	 be	 considered	 compli‐
cated.	 Thus,	 one	 of	 the	 aims	 of	 the	 presented	 work	 was	 to	
develop	 simple	 spectrophotometric	methods	 based	 on	 smart	
original	mathematical	techniques	with	few	manipulation	steps	
for	analyzing	the	binary	mixture	of	LEV	and	EE,	consequently,	
was	 to	 conduct	 a	 comparative	 study	 between	 the	 different	
proposed	methods;	this	comparison	was	mainly	regarding	the	
ability	of	the	developed	methods	to	resolve	binary	mixture	of	
spectral	 interfering	 problem	 without	 preliminary	 separation	
in	 terms	 of	 specificity	 and	 validation.	 Another	 aim	 was	 to	
perform	an	HPTLC	method	on	Nano	Silica	Gelplates	where	the	
small	 particle	 size	 of	 the	 plates	 would	 add	 privileges	 of	
enhancing	 the	 sensitivity,	 offering	 better	 separation	 and	
providing	wider	 linearity	 range	 than	 the	previously	 reported	
HPTLC	 methods	 [14‐15].	 All	 the	 proposed	 methods	 were	
found	to	be	simple,	precise	and	accurate	in	addition,	they	were	
independent	 on	 any	 sophisticated	 apparatus	 or	 computer	
programs.	
	
2.	Experimental	
	
2.1.	Apparatus	and	software	
	
The	 spectrophotometric	 measurements	 were	 carried	 out	
with	a	 JASCO	V‐530	double	beam	UV‐VIS	 spectrophotometer.	
Spectral	acquisition	and	elaboration	of	the	obtained	data	was	
done	 using	 a	 Spectra	 Manager	 Program	 (JASCO).	 Quartz	
cuvettes	 (1	 cm	 path	 length)	were	 utilized	 for	measuring	 the	
light	absorption	in	the	ultraviolet	region	(200‐350	nm).	
The	 HPTLC	 measurements	 were	 carried	 out	 using	 a	
CAMAG	TLC	 Scanner	 3	 S/N	130319	operated	with	win	CATS	
software,	 Linomat	 5	 autosampler	 (CAMAG,	 Muttenz,	
Switzerland),	CAMAG	microsyringe	 (100	µL),	 and	Nano	Silica	
Gel	on	TLC	plates	for	HPTLC	with	fluorescent	indicator	254	nm	
glass	plates	(10	×	20	cm)	with	6.0‐9.0	µm	particle	size	(Sigma‐
Aldrich	by	Merck	KGaA,	Darmstadt,	Germany)	were	used.	
2.2.	Chemicals		
	
Pure	 samples:	 Levonorgestrel	 and	 ethinyl	 estradiol	 were	
kindly	 supplied	 by	 NODCAR	 (El	 Haram,	 Giza,	 Egypt).	 Their	
purities	were	 found	to	be	99.40%±1.01	and	99.72%±0.75	 for	
LEV	and	EE,	respectively,	by	the	pharmacopoeial	method	[8].	
Market	sample:	Microcept	labeled	to	contain	0.150	mg	LEV	
and	0.03	mg	EE	 (Batch	number:	 1402217),	manufactured	 by	
Chemical	 Industries	 development	 CID	 (Giza,	 Egypt)	 was	
purchased	from	local	market.	
Solvents:	Methanol	was	obtained	from	Merck	(Darmstadt,	
Germany)	 and	 chloroform	 was	 of	 analytical	 grade	 obtained	
from	POCh	(Gliwice,	Poland).	
	
2.3.	Standard	solutions	
	
Stock	solutions:	Separate	(1	mg/mL)	solutions	of	LEV	and	
EE	were	 prepared	 in	methanol.	Working	 solutions:	 Solutions	
of	(0.1	mg/mL)	for	each	of	LEV	and	EE	were	freshly	prepared	
by	dilution	from	the	stock	solutions	with	methanol.	
	
2.4.	Procedures	
	
2.4.1.	Spectral	characteristics		
	
The	 zero‐order	 absorption	 spectra	 (D0)	 of	 standard	
solutions	 of	 final	 concentration	 1‐65	 µg/mL	 LEV	 and	 1‐95	
µg/mL	EE	were	recorded	over	the	wavelength	range	200‐350	
nm	against	methanol	as	a	blank.	
	
2.4.2.	HPTLC‐densitometric	method	
	
The	 samples	 were	 applied	 to	 the	 Nano	 HPTLC	 plates	 as	
bands	using	a	100	µL	syringe.	The	band	width	was	6	mm	and	
the	 bands	were	 spaced	 at	 about	 1	 cm	 apart	 from	 each	 other	
and	1	 cm	 from	 the	bottom	edge	of	 the	plate.	 The	developing	
system	 was	 chloroform:	 methanol	 (99:1,	 v:v).	 The	 chroma‐
tographic	 tank	 was	 left	 to	 be	 saturated	 with	 the	 developing	
system	 at	 room	 temperature	 for	 1	 h	 then	 linear	 ascending	
development	was	performed	to	a	distance	of	approximately	8	
cm	from	the	lower	edge.	The	developed	plates	were	air‐dried	
and	scanned	at	254	nm.	The	detection	was	carried	out	with	the	
aid	 of	 CAMAG	 TLC	 Scanner	 3	 which	 was	 operated	 in	 the	
absorbance	 mode	 using	 a	 deuterium	 lamp	 as	 the	 source	 of	
radiation,	keeping	the	slit	dimension	at	3	mm	×	0.45	mm,	and	
the	scanning	speed	at	20	mm/s.	
	
2.4.3.	Construction	of	calibration	curves	
	
For	 ratio	 subtraction	 method	 (RS);	 a	 calibration	 curve	
relating	 the	 zero	 order	 spectra	 of	 LEV	 at	 240	 nm	 versus	 its	
corresponding	 concentrations	 was	 constructed	 and	 the	
regression	equation	was	computed.	
For	 ratio	 difference	 (RD)	 and	 derivative	 ratio	 (DR)	
methods;	 the	 absorption	 spectra	 of	 LEV	were	 divided	 by	 the	
absorption	 spectrum	 of	 75	 µg/mL	 EE.	 While	 the	 absorption	
spectra	of	EE	were	divided	by	the	absorption	spectrum	of	25	
µg/mL	LEV.	The	obtained	ratio	spectra	were	recorded.	These	
ratio	spectra	were	utilized	for	both	(RD)	and	(DR)	methods.	In	
the	 (RD)	 method;	 calibration	 curves	 relating	 the	 difference	
between	 the	 amplitudes	 of	 the	 obtained	 ratio	 spectra	 at	 247	
and	 268	 nm	 and	 between	 282	 and	 247	 nm	 versus	 the	
corresponding	 concentrations	 of	 LEV	 and	 EE,	 respectively,	
were	 constructed.	 Then,	 the	 regression	 equations	 were	
computed.	However,	for	the	DR	method;	the	first	derivative	of	
these	 ratio	 spectra	 was	 computed.	 Calibration	 curves	 were	
constructed	 by	 plotting	 the	 amplitudes	 at	 254	 and	 296	 nm	
against	 the	 corresponding	 concentrations	 of	 LEV	 and	 EE,	
respectively.	Then,	the	regression	equations	were	computed.	
For	 absorbance	 subtraction	 method	 (AS);	 calibration	
curves	relating	the	zero	order	spectra	of	LEV	or	EE	at	267	nm	
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versus	 the	 corresponding	 concentrations	 were	 constructed	
and	the	regression	equations	were	computed.	The	absorbance	
factor	 of	 EE	 [A267/A280]	 was	 calculated	 and	 was	 found	 to	 be	
0.47.	
For	 Amplitude	modulation	 method	 (AM);	 the	 absorption	
spectra	 of	 the	 standard	 solutions	 were	 divided	 by	 the	 EE	
normalized	 divisor	 spectrum	 and	 the	 obtained	 ratio	 spectra	
were	 recorded.	 Calibration	 curves	 relating	 the	 amplitudes	 of	
LEV	 or	 EE	 at	 267	 nm	 against	 their	 corresponding	 concent‐
rations	 were	 plotted	 and	 the	 regression	 equation	 was	
computed.	
For	HPTLC;	separate	aliquots	were	accurately	transferred	
from	the	working	standard	solutions	of	each	drug	 to	prepare	
solutions	 of	 4	 and	 100	 µg/mL	 for	 LEV	 and	 EE,	 respectively,	
which	 were	 used	 to	 construct	 the	 calibration	 curves.	 The	
chromatographic	 conditions	 were	 applied,	 and	 the	 chroma‐
tograms	were	recorded.	The	calibration	curves	were	construc‐
ted	in	the	range	of	0.02‐3	µg/band	and	0.5‐20	µg/band	for	LEV	
and	EE,	respectively,	by	plotting	the	relative	peak	area	at	254	
nm	against	the	corresponding	concentration;	consequently	the	
regression	equations	were	calculated.	
	
2.4.4.	Application	to	laboratory	prepared	mixtures	
	
For	 the	 spectrophotometric	 methods;	 seven	 mixtures	
containing	 different	 ratios	 of	 LEV	 and	 EE	were	 prepared	 by	
transferring	 accurate	 aliquots	 from	 their	 working	 solutions	
into	 a	 series	 of	 10‐mL	 volumetric	 flasks;	methanol	was	 used	
for	completing	the	volumes.	Then,	the	spectra	of	the	mixtures	
were	recorded	at	200‐350	nm.	The	concentration	of	each	drug	
was	calculated	by	substitution	in	the	corresponding	regression	
equation	after	applying	the	corresponding	manipulating	steps	
for	 each	 method.	 In	 case	 of	 ratio	 subtraction	 method,	 the	
spectra	 of	 the	 mixture	 were	 divided	 by	 the	 spectrum	 of	 75	
µg/mL	 EE	 as	 a	 divisor	 to	 obtain	 the	 corresponding	 ratio	
spectra.	 The	 constant	 was	 measured	 at	 the	 plateau	 region	
(274‐292	nm)	 then	 it	was	 subtracted	 from	 the	 ratio	 spectra.	
The	obtained	spectra	were	then	multiplied	by	the	spectrum	of	
75	μg/mL	of	EE.	
For	 the	 HPTLC	 densitometric	 method;	 five	 mixtures	
containing	different	ratios	of	the	cited	drugs	were	prepared	by	
transferring	 accurate	 aliquots	 from	 their	 working	 solutions	
into	a	series	of	10	mL	volumetric	flasks,	then	the	volumes	were	
completed	with	methanol.	
	
2.4.5.	Application	to	pharmaceutical	preparation	
	
Twenty	 tablets	 were	 triturated	 and	 mixed	 well.	 An	
accurate	amount	of	the	powder	equivalent	to	2.89	mg	LEV	and	
0.578	mg	EE	was	weighed	and	transferred	 into	a	beaker.	The	
powder	 was	 mixed	 with	 25	 mL	 methanol	 and	 sonicated	 for	
about	30	min.	The	obtained	solution	was	then	filtered	into	50	
mL	 volumetric	 flask	 and	 the	 volume	 was	 completed	 with	
methanol,	thus	a	stock	solution	was	prepared.	
For	 the	 spectrophotometric	 methods;	 an	 aliquot	
equivalent	 to	 8.65	 mL	 from	 the	 stock	 solution	 were	 trans‐
ferred	 to	 10	 mL	 volumetric	 flask	 and	 the	 volume	 was	
completed	with	methanol	to	obtain	a	final	concentration	of	50	
µg/mL	 for	 LEV	 and	 10	 µg/mL	 for	 EE.	 The	 concentration	 of	
each	drug	was	calculated	using	 the	corresponding	 regression	
equation	after	applying	the	corresponding	manipulating	steps	
for	each	method.		
While,	 for	 the	HPTLC	method;	 4.35	mL	aliquots	 from	 the	
stock	 solution	 were	 transferred	 to	 100	 mL	 volumetric	 flask	
and	the	volume	was	completed	with	methanol	to	obtain	a	final	
concentration	of	2.5	µg/mL	for	LEV	and	0.5	µg/mL	for	EE.	The	
concentration	 of	 each	 drug	 was	 calculated	 using	 the	
corresponding	regression	equation.	
To	apply	the	standard	addition	technique,	different	known	
concentrations	 of	 pure	 standard	 of	 each	 drug	were	 added	 to	
the	 dosage	 form	 before	 proceeding	 in	 the	 previously	
mentioned	methods.	
	
3.	Results	and	discussion	
	
Resolution	 of	 binary	 or	 ternary	 mixtures	 possessing	
overlapped	 spectra	 is	 an	 interesting	 as	 well	 as	 challenging	
issue	 for	 the	analytical	 chemistry.	Although,	HPLC‐UV,	LC‐MS	
and	GC‐MS,	etc.	 are	 the	methods	of	 choice	 for	 analyzing	such	
mixtures,	 however,	 in	 the	 last	 few	 years	 the	 development	 of	
mathematical	 spectrophotometric	 methods	 has	 greatly	
replaced	 these	 techniques	with	 the	privilege	 of	being	easy	 to	
apply,	rapid,	do	not	require	optimization	of	conditions	such	as	
pH,	 temperature	 or	 flow	 rate,	 sensitive	 and	 yet	 highly	
economical	 [24,25].	 Thus,	 we	 were	 motivated	 to	 develop	
sensitive	 spectrophotometric	 methods	 for	 the	 simultaneous	
analysis	of	LEV	and	EE	in	their	bulk	powders	and	dosage	form	
with	 acceptable	 accuracy	 and	 precision	 specifically	 as	 the	
literature	 reveals	 only	 few	 spectrophotometric	 methods	 for	
their	determination	as	previously	cited	in	the	introduction.	We	
were	 aiming	 to	 perform	 simple	 methods	 with	 few	 manipu‐
lating	steps	to	overcome	the	disadvantage	of	 the	complicated	
calculations	 of	 the	 previously	 developed	 H‐point	 standard	
addition	methods	[21‐23].		
Besides,	 the	 emergence	 of	 Nano	 Silica	 Gel	 plates	
possessing	small	particle	size	and	pore	diameter;	an	advantage	
which	 is	expected	 to	enhance	the	sensitivity	and	to	demonst‐
rate	 better	 separation	 has	 encouraged	 us	 to	 carry	 out	 an	
HPTLC	method	with	the	aim	to	determine	LEV	and	EE	at	lower	
concentrations	and	wider	range	than	the	previously	reported	
densitometric	methods	[14‐15].	
	
3.1.	Spectrophotometric	methods	
	
By	 scanning	 the	 absorption	 spectra	 of	 LEV	 and	 EE,	
severely	 overlapped	 spectral	 bands	 were	 observed	 in	 the	
wavelength	region	of	200‐350	nm	(Figure	2).	Although	EE	can	
be	determined	 at	 its	 λmax	 at	 280	nm,	however,	 this	 could	not	
provide	 simultaneous	 determination	 of	 both	 drugs.	 In	
addition,	 EE	 had	 an	 absorbance	 at	 240	 nm	 hindering	 the	
determination	 of	 LEV	 at	 its	 λmax	 240	 nm.	 Thus,	 different	
mathematical	 spectrophotometric	 methods	 were	 applied	 for	
achieving	 best	 resolution	 and	 quantitative	 determination	 of	
each	drug	without	any	interference	from	the	other.	
	
	
	
Figure	2.	Absorption	spectra	of	40	µg/mL	LEV	(‐.‐.‐‐.‐.),	40	µg/mL	EE	(…….)	
and	a	binary	mixture	of	20	µg/mL	of	each	LEV	and	EE	(─).	
	
3.1.1.	Ratio	difference	method	(RD)	
	
The	overlapped	spectra	of	LEV	and	EE	have	suggested	that	
the	 ratio	 difference	 spectrophotometric	 method	 could	 be	 a	
suitable	 method	 for	 their	 simultaneous	 determination.	 Lotfy	
and	Hegazy	[26]	have	introduced	the	ratio	difference	spectro‐
photometric	method	 (RD)	which	depended	on	measuring	 the	
difference	between	two	amplitude	values	at	 two	wavelengths	
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using	the	ratio	spectra	[27‐29].	In	the	ratio	difference	method	
the	 noise	 is	 cancelled	 because	 the	 difference	 between	 the	
amplitude	 values	 was	 measured	 by	 subtraction	 of	 the	 two	
values	at	the	two	selected	wavelengths.	
For	 the	 determination	 of	 the	 drugs;	 LEV	 (1‐65	 μg/mL)	
spectra	 were	 divided	 by	 the	 spectrum	 of	 EE	 (75	 μg/mL)	
(Figure	3a)	and	EE	(1‐95	μg/mL)	spectra	were	divided	by	the	
spectrum	of	LEV	(25	μg/mL)	(Figure	3b).	The	concentration	of	
LEV	 was	 calculated	 by	 using	 the	 regression	 equation	
representing	the	linear	relationship	between	the	differences	of	
amplitudes	of	the	ratio	spectra	at	247	and	268	nm	versus	the	
corresponding	 concentration	 of	 the	 drug.	 The	 selection	 of	
these	 two	 wavelengths	 was	 based	 on	 the	 fact	 that	 the	 ratio	
spectrum	 of	 LEV	 has	 shown	 significant	 difference	 in	 the	
amplitude	 values	 at	 these	 two	 wavelengths	 with	 different	
concentrations,	while	the	ratio	spectrum	of	EE	has	shown	the	
same	 amplitudes	 at	 these	 wavelengths	 (i.e.	 constant).	
Similarly,	EE	could	be	determined	 in	 the	same	manner	at	 the	
selected	wavelengths	(282	and	247	nm).		
In	 order	 to	 attain	 the	 least	 noise,	 the	 smoothest	 ratio	
spectra	 and	 the	 highest	 sensitivity;	 the	 effect	 of	 the	 divisor	
concentration	 was	 tested.	 Thus,	 different	 concentrations	 of	
LEV	 (15,	 25	 and	 35	 μg/mL)and	 EE	 (20,	 60	 and	 75	 μg/mL)	
were	tried	as	a	divisor	but	the	concentrations	25	μg/mL	of	LEV	
and	75	 μg/mL	of	EE	has	 shown	 the	 best	 results.	 In	 addition,	
the	 selected	 wavelengths	 have	 proved	 to	 be	 the	 best	
concerning	 the	 average	 recovery	 percent	 when	 used	 for	
estimating	 the	 concentrations	 of	 LEV	 and	EE	 in	bulk	powder	
and	in	laboratory	prepared	mixtures.	
	
	
	
	
	
Figure	3.	Ratio	spectra	of	(a)	LEV	(1.0‐65.0	µg/mL)	using	75.0	µg/mL	EE	as	
a	divisor	and	 (b)	EE	 (1.0‐95.0	µg/mL)	using	25.0	µg/mL	LEV	as	 a	divisor,	
both	spectra	showing	the	two	selected	maxima	and	minima.	
	
3.1.2.	Ratio	subtraction	method	(RS)	
	
The	 ratio	 subtraction	method	 (RS)	 [30]	was	used	 for	 the	
determination	 of	 LEV	 concentration	 in	 the	 binary	mixture	 of	
LEV	and	EE.	The	spectrum	of	the	binary	mixture	was	divided	
by	 a	 known	 concentration	 of	 EE	 as	 a	 divisor	 (75	 μg/mL)	
(Figure	 4a).	 The	 constant	 obtained	 from	 the	 division	 was	
measured	 at	 the	 plateau	 (274‐292	 nm).	 By	 subtracting	 this	
constant	 value	 (Figure	 4b),	 then	 multiplying	 the	 obtained	
curve	after	subtraction	by	the	spectrum	of	75	μg/mL	of	EE	(the	
divisor),	we	could	recover	the	zero	order	absorption	spectrum	
of	LEV	present	in	the	mixture.	Thus	its	concentration	could	be	
measured	at	its	λmax	(240	nm)	(Figure	4c).	
	
	 	
	
	
	
					 	
Figure	 4.	 (a)	 Division	 spectra	 of	 laboratory	 prepared	 mixtures	 using	 75	
µg/mL	 EE	 as	 a	 divisor,	 (b)	 Division	 spectra	 after	 subtraction	 of	 the	
constants,	 (c)	The	 obtained	 zero	 order	 spectra	 of	 LEV	after	 subtraction	of	
constant	and	multiplication	by	the	spectrum	of	75	µg/mL	EE.	
	
3.1.3.	Derivative	ratio	method	(DR)	
	
This	method	has	 depended	 on	 division	 of	 the	 absorption	
spectrum	of	one	component	by	 the	 second	one	 (as	a	divisor)	
and	then	the	first	derivative	of	the	obtained	ratio	spectra	was	
computed	[31‐33].	The	overlapped	spectra	of	LEV	and	EE	have	
suggested	 the	 utilization	 of	 derivative	 ratio	method	 for	 their	
determination.	Thus,	LEV	(1‐65	μg/mL)	spectra	were	divided	
by	 the	 spectrum	 of	 EE	 (75	 μg/mL)	 and	 EE	 (1‐95	 μg/mL)	
spectra	 were	 divided	 by	 the	 spectrum	 of	 LEV	 (25	 μg/mL)	
followed	 by	 computing	 the	 first	 derivative	 of	 the	 obtained	
ratio	 spectra	as	shown	 in	Figure	5.	The	concentration	of	LEV	
and	 EE	 were	 calculated	 by	 using	 the	 regression	 equations	
representing	 the	 linear	 relationship	 between	 the	 peak	
amplitudes	 at	 254	 and	 296	 nm	 versus	 the	 corresponding	
concentrations	 of	 the	 two	 drugs,	 respectively.	 In	 order	 to	
optimize	 the	 developed	 derivative	 ratio	 spectrophotometric	
method,	 the	 influence	 of	 different	 variables	 including	 divisor	
concentration,	 smoothing	 factor	 and	 working	 wavelengths,	
were	studied.	Consequently	25	μg/mL	of	LEV	and	75	μg/mL	of	
EE	 as	 divisors	 have	 given	 minimum	 noise,	 smoother	 ratio	
spectra	 and	 maximum	 sensitivity.	 The	 selected	 wavelengths	
have	 proved	 to	 be	 the	 best	 concerning	 the	 average	 recovery	
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percent	when	 used	 for	 estimating	 the	 concentrations	 of	 LEV	
and	EE	in	bulk	powder	and	in	laboratory	prepared	mixtures.	
	
	
	
	
	
Figure	5.	First	derivative	of	ratio	spectra	of:	(a)	LEV	(1‐65	µg/mL)	using	75	
µg/mL	EE	as	a	divisor	and	(b)	EE	(1‐95	µg/mL)	using	25	µg/mL	LEV	as	a	
divisor.	
	
3.1.4.	Absorbance	subtraction	method	(AS)	
	
This	 method	 was	 based	 on	 the	 same	 principle	 as	 the	
absorption	 factor	 method	 [34‐37].	 The	 method	 has	 mainly	
depended	on	the	presence	of	an	isoabsorptive	point	in	the	zero	
order	absorption	spectra	of	the	drugs	(λiso	267	nm)	where	the	
drugs	have	 equal	 absorptivities	 at	 this	 point.	 In	 addition,	 the	
spectrum	 of	 EE	 was	 extended	 over	 the	 LEV.	 For	 the	
determination	of	LEV	and	EE,	their	isosbestic	point	at	267	nm	
was	utilized	(Figure	2).	The	absorbance	of	EE	at	267	nm	was	
calculated	 using	 its	 absorbance	 factor	 at	 this	 point	 (where	
[A267/A280]	 for	 EE	 was	 found	 to	 be	 0.47),	 and	 then	 the	
absorbance	 of	 LEV	 was	 obtained	 by	 subtraction.	 The	
absorbance	values	of	EE	and	LEV	at	λiso	267	nm	were	used	to	
calculate	 each	 of	 their	 concentration	 using	 the	 unified	
regression	equation	at	the	same	wavelength.	
	
AEE	at	267	nm	=	[A267/A280]	(Amix	at	280	nm)		 	 (1)	
	
ALEV	at	267	nm=	Amix	at	267	nm	–	AEE	at	267	nm	 	 (2)	
	
where	 Amix	 is	 the	 absorbance	 of	 the	 binary	mixture,	 AEE	 and	
ALEV	 are	 the	 absorbance	 of	 EE	 and	 LEV,	 respectively,	 and	
[A267/A280]	 is	 the	 absorbance	 factor	 of	 pure	 EE	 at	 267	nm	 to	
that	at	280	nm.	
	
3.1.5.	Amplitude	modulation	method	(AM)	
	
This	 proposed	method	 has	 depended	 on	 the	 presence	 of	
isosbestic	 point	 in	 the	 absorption	 spectrum	which	would	 be	
retained	at	the	same	point	in	the	ratio	spectrum	(after	division	
by	one	component	as	a	divisor).	 In	addition,	 the	extension	of	
the	 spectra	 of	 one	 component	 was	 another	 requirement	
[34,36].	The	AM	method	has	depended	on	the	utilization	of	the	
normalized	divisor	to	eliminate	 the	effect	of	 the	choice	of	 the	
divisor	which	greatly	affects	 the	results	of	manipulating	ratio	
spectra	techniques.	Thus,	to	eliminate	the	effect	of	the	divisor,	
the	normalized	spectrum	of	EE	was	used.	
By	 dividing	 the	 spectrum	 of	 the	 binary	 mixture	 by	 the	
normalized	 EE	 divisor	 spectrum,	 the	 ratio	 spectrum	 was	
obtained	(Figure	6).	The	amplitude	value	of	 the	constant	was	
determined	 at	 the	 plateau	 region	 at	 274‐292	nm,	which	was	
equal	 to	 the	amplitude	of	 the	constant	of	EE	along	 the	whole	
spectrum.	 Since	 at	 the	 isosbestic	 point	 (λiso)	 at	 267	 nm,	 the	
amplitude	 of	 the	 ratio	 spectra	 at	 this	 point	was	 equal	 to	 the	
sum	of	the	amplitudes	of	EE	and	LEV.	Thus,	by	subtracting	the	
previously	obtained	constant,	the	corresponding	amplitude	of	
LEV	 was	 obtained,	 which	 was	 equivalent	 to	 the	 recorded	
concentration	of	LEV	in	the	mixture	(CRecorded	of	LEV).	
	
	
	
	
	
Figure	6.	(a)	Ratio	spectra	of	laboratory	prepared	mixture	of	20.0	µg/mL	of	
each	of	EE	and	LEV	using	normalized	EE	as	a	divisor	and	(b)	ratio	spectra	of	
laboratory	 prepared	mixture	 of	 20.0	 µg/mL	 of	 each	 of	 EE	 and	 LEV	 using	
normalized	EE	as	a	divisor	after	subtraction	of	constant.	
	
To	 eliminate	 any	 error	 due	 to	 signal	 to	 noise	 ratio,	 the	
actual	 concentration	 of	 EE	 or	 LEV	 were	 calculated	 by	 using	
their	 corresponding	 unified	 regression	 equation	 at	 λiso	 =	 267	
nm.	
	
CRecorded	=	1.005	C+	0.070	 	 	 	 (3)	
	
where	 CRecorded	 represented	 the	 recorded	 amplitude	 of	 ratio	
spectrum	which	 was	 equal	 to	 the	 recorded	 concentration	 of	
LEV	and	Crepresented	corresponding	concentration	of	LEV.		
The	 developed	 spectrophotometric	 methods	 have	
introduced	several	advantages;	where	the	RD	method	has	the	
advantage	 of	 complete	 elimination	 of	 the	 interfering	
component	 in	 the	 form	of	 a	 constant	 so	 there	 is	 no	need	 for	
critical	measurements;	 this	 leads	 to	 reproducible	 and	 robust	
results.	The	advantage	of	RS	is	that	the	component	of	interest	
is	 recovered	 in	 its	 zero	 order	 spectra	 and	 is	measured	 at	 its	
λmax	 thus,	minimizing	 the	noise	error.	The	main	advantage	of	
DR	 method	 is;	 allowing	 the	 use	 of	 the	 wavelength	 with	 the	
highest	 value	either	maximum	or	minimum.	Additionally,	 the	
presence	of	a	 lot	of	maxima	and	minima	gives	a	good	chance	
for	the	analysis	of	an	active	compound	in	the	presence	of	other	
active	 ingredients	 which	 can	 possibly	 interfere	 with	 the	
analysis.	The	advantage	of	the	AS	and	AM	methods	is	that	both	
components	 in	 a	 mixture	 can	 be	 determined	 using	 unified	
regression	equation	at	λiso.	An	additional	privilege	for	the	AM	
method	 is	 the	 use	 of	 the	 normalized	 divisor,	 where	 the	
obtained	amplitude	at	the	ratio	spectrum	will	directly	repre‐	
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Table	1.	Assay	parameters	and	validation	sheet	obtained	by	applying	the	proposed	methods.	
Parameter	 RD	 RS	 DR	 AM	 AS	 HPTLC	
LEV	 EE	 LEV	 LEV EE LEV EE LEV EE LEV	 EE
Wavelength	
(nm)	
P1‐P2	
247‐268	
P1‐P2	
282‐247	
D0	at	240	 P	at	254	 P	at	296	 P	at	267	 D0	at	267	 At	254	
Calibration	
range	a	
1‐65	
µg/mL	
1‐95	
µg/mL	
1‐65	
µg/mL	
1‐65	
µg/mL	
1‐95	
µg/mL	
1‐65
µg/mL	
1‐65
µg/mL	
0.02‐3.00	
µg/band	
0.5‐20.0	
µg/band	
Slope	 0.9971	 0.2778	 0.0529	 0.0732 0.0151 1.0060 0.0035 0.1083	 0.2219
Intercept	 0.9218	 0.0297	 0.0578	 0.0206 0.0076 0.0700 0.0030 0.0018	 0.0770
Correlation	
coefficient	
0.9996	 0.9998	 0.9995	 0.9995 0.9999 0.9997 0.9997 0.9998	 0.9995
Mean	a	 99.4	 100.1	 99.9	 100.1	 99.9	 99.9	 99.4	 99.4	 99.7	 99.7	 101.1	
RSD%	 1.01	 1.07	 1.14	 1.35	 0.97	 0.93	 0.76	 1.38	 0.98	 1.31	 1.36	
SE	of	slope	 8.28×10‐3	 1.97×10‐3	 4.53×10‐4	 9.99×10‐4	 9.26×10‐5	 8.17×10‐3	 2.48×10‐5	 1.19×10‐5	 8.62×10‐4	
SE	of	intercept	 3.06×10‐1	 1.08×10‐1	 1.624×10‐2 3.72×0‐2 5.09×10‐3 2.76×10‐1 9.16×10‐4 1.58×10‐2	 9.64×10‐3
LOD	 0.13	 0.25	 0.18	 0.22	 0.30	 0.28	 0.17	 0.015	 0.42	
LOQ	 0.39	 0.76	 0.55	 0.67 0.91 0.85 0.52 0.047	 1.27
Repeatability	
a,b	
0.69	 0.59	 0.66	 0.55 0.65 0.79 0.65 0.75 0.64	 0.32	 0.86
Inter‐day	
precision	a,b	
0.64	 0.72	 0.74	 0.95 0.71 0.91 0.84 0.72 0.80	 0.48	 1	
a	Average	of	three	experiments.	
b	Relative	standard	deviation	of	three	concentrations	(10,	35	and	60	µg/mL)	of	each	drug	for	the	spectrophotometric	method	and	of	three	concentrations	of	
LEV	(0.3,	0.5	and	1.0	µg/band)	and	EE	(5,	10	and	15	µg/band)	for	HPTLC	method.	
	
sent	 the	 concentration	 of	 each	 component	 and	 thus	 the	
absorbance	factor	step	is	eliminated.	
	
3.2.	HPTLC	method	
	
This	 method	 has	 offered	 a	 simple	 way	 to	 separate	 and	
quantify	 LEV	 and	 EE	 directly	 on	HPTLC	plates	 by	measuring	
the	 optical	 density	 of	 the	 separated	 bands.	 Several	 solvent	
systems	 were	 tried	 for	 the	 best	 separation	 of	 the	 drugs.	
However,	chloroform:	methanol	(99:1,	v:v)	has	provided	good	
resolution	and	sharp	symmetrical	peaks.	The	band	width	was	
chosen	 to	 be	 6	 mm	 in	 order	 to	 minimize	 band	 diffusion.	
Moreover,	the	scanning	wavelength	was	chosen	to	be	254	nm	
which	 has	 resulted	 in	 sharp	 and	 symmetrical	 peaks	 with	
minimum	noise.	The	Rf	values	were	0.55	and	0.40	for	LEV	and	
EE,	 respectively.	 A	 typical	 chromatogram	 is	 demonstrated	 in	
Figure	 7	 in	 which	 the	 separation	 has	 allowed	 for	 the	
determination	of	the	drugs	without	any	interference	from	each	
other.	 The	 HPTLC	 method	 has	 the	 advantages	 of	 requiring	
simple	 developing	 systems	 with	 no	 pH	 adjustments,	
additionally,	several	samples	can	be	run	simultaneously	with	a	
small	quantity	of	the	mobile	phase,	thus	offering	less	analysis	
time	and	cost	per	analysis.	 In	comparison	to	other	developed	
HPTLC	methods	 for	 the	simultaneous	analysis	of	LEV	and	EE	
[14‐15]	 our	 proposed	 method	 has	 offered	 higher	 sensitivity	
and/or	 wider	 concentration	 range	 which	 is	 referred	 to	 the	
utilization	 of	 the	 Nano	 HPTLC	 plates.	 LEV	 and	 EE	 were	
determined	in	the	concentration	range	of	0.02‐3	ug/band	and	
0.50‐20	ug/band,	respectively.	
	
3.3.	Methods	validation	
	
Methods	 validation	 was	 performed	 according	 to	 ICH	
guidelines	[38]	for	the	proposed	methods	as	follows:		
	
3.3.1.	Linearity	and	range	
	
The	 linearity	 of	 the	 proposed	methods	was	 estimated	 by	
constructing	the	different	calibration	curves	on	three	different	
days.	The	linearity	of	the	calibration	curves	were	validated	by	
the	high	value	of	correlation	coefficients.	The	analytical	data	of	
the	 calibration	 curve	 including	 concentration	 ranges,	 calib‐
ration	 equations,	 standard	 error	 of	 the	 slope	 and	 intercept	
were	summarized	in	Table	1.	
	
3.3.2.	Accuracy	
	
The	 procedures	 under	 construction	 of	 the	 calibration	
curves,	 for	both	drugs	using	 the	different	proposed	methods,	
were	 repeated	 three	 times	 for	 the	 determination	 of	 seven	
concentrations	of	pure	LEV	and	EE	within	the	linearity	range.	
The	 accuracy	 expressed	 in	 terms	 of	 percentage	 recoveries	
(mean)	 and	 standard	 deviation	was	 shown	 in	 Table	 1.	 Good	
accuracy	 of	 the	 developed	 methods	 was	 indicated	 by	 the	
obtained	results.		
	
	(a)	
	
(b)	
	
Figure	7.	(a)	HPTLC	chromatogram	and	(b)	Three	dimensional	(3D)	HPTLC	
chromatogram	 of:	 the	 separated	 peaks	 of	 LEV	 (Rf	 =	 0.55)	 over	 the	
concentration	 range	 of	 0.02‐3.00	 µg/band	 and	 EE	 (Rf	 =	 0.40)	 over	 the	
concentration	range	of	0.5‐20.0	µg/band	using	chloroform:	methanol	(99:1,	
v:v)	as	the	mobile	phase.	
	
3.3.3.	Precision	
	
The	 intra‐day	 and	 inter‐day	 precision	 of	 the	 proposed	
methods	 were	 determined	 by	 the	 analysis	 of	 three	 different	
concentrations	 of	 pure	 LEV	 and	 EE,	 each	 three	 times	 on	 a	
single	 day	 and	 on	 three	 consecutive	 days,	 respectively.	 The	
results	were	illustrated	in	Table	1.	
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Table	2.	Analysis	of	laboratory	prepared	mixtures	by	the	proposed	methods.	
Conc.	in	µg/mL	
LEV	:	EE	
Spectrophotometric	methods	 HPTLC	method	
RD	 RS	 DR	 AM AS Conc.	in		
µg/band	LEV	:	EE	
LEV	 EE
LEV	 EE	 LEV	 LEV	 EE	 LEV	 EE	 LEV	 EE	
25	:	25	 100.4	 100.6	 100.7	 101.1	 99.6 100.4 101.0 98.9 99.9 1:2 100.1 98.2
50	:	25	 99.3	 100.9	 101.8	 100.7	 99.9 101.8 101.4 99.7 99.9 2:1 101.9 101.2
25	:	5b	 101.2	 97.8	 100.9	 100.8	 99.3 100.8 99.8 100.9 100.3 3:0.6	b 98.7	 101.8
50:	10	 99.6	 101.8	 99.9	 100.8	 101.07 101.4 101.5 100.5 100.6 1:5 99.9	 98.5
10	:	10	 101.0	 99.5	 101.6	 101.8	 100.9 100.5 99.9 101.8 100.3 2:2 101.9 99.7
20	:	20	 101.2	 101.3	 101.1	 100.8	 100.9	 100.5	 101.0	 98.5	 100.2	 	
60:	12	b	 100.4	 99.9	 98.7	 99.4	 99.7 100.2 100.8 101.9 99.4
Mean	a	 100.4	 100.3	 100.7	 100.8	 100.2	 100.8	 100.8	 100.3	 100.1	 	 100.5	 99.9	
RSD%	 0.75	 1.33	 1.06	 0.71	 0.74	 0.59	 0.65	 1.34	 0.51	 1.39	 1.59	
SEM	 0.28	 0.37	 0.39	 0.27	 0.28 0.22 0.24 0.51 0.19 0.616 0.586
Variance	 0.56	 1.78	 1.13	 0.51	 0.55 0.36 0.43 1.82 0.26 2.48	 1.97
a	Average	of	three	experiments.	
b	Ratio	present	in	dosage	form.	
	
Table	3.	Application	of	standard	addition	technique	to	the	analysis	of	dosage	form	by	applying	the	proposed	methods.	
Methods	 LEV	 EE
Found	a,	b	 Found	c	
Recovery	%	±	SD	
Pure	added	d,	e	
Recovery	%	±	SD	
Found	in	µg/mL	a,	b	 Found	c	
Recovery	%	±	SD	
Pure	added	d,	e	
Recovery	%	±	SD	
RD	 50.19	µg/mL	 100.4±1.09	 99.9±1.24 10.03 100.3±0.79 99.7±0.75
RS	 50.06	µg/mL	 100.1±1.06	 99.9±1.07
DR	 50.12	µg/mL	 100.2±0.87	 100.1±1.00 10.07 100.7±0.91 99.8±0.78
AM	 50.07	µg/mL	 100.1±0.76	 99.8±0.92	 10.06	 100.6±0.58	 100.0±0.86		
AS	 50.04	µg/mL	 100.1±0.77		 99.9±1.20 10.01 100.1±0.89 99.9±0.90
HPTLC	 2.49	µg/band	 99.8±1.08	 100.7±1.05	 0.5002	 100.0±1.37	 100.2±1.26	
a	For	the	spectrophotometric	methods;	LEV	is	claimed	to	be	50	µg/mL	and	EE	is	claimed	to	be	10	µg/mL.	
b	For	the	HPTLC	method	LEV	is	claimed	to	be	2.5	µg/band	and	EE	is	claimed	to	be	0.5	µg/band.	
c	Average	of	five	experiments.	
d	Average	of	three	experiments	(added	equivalent	to	2.5,	5,	7.5,	10,	15	µg/mL	LEV	and	10,	20,	30,	40,	50	µg/mL	EE)	for	the	spectrophotometric	methods.	
e	Average	of	three	experiments	(added	equivalent	to	0.1,	0.2,	0.3,	0.4,	0.5	µg/band	LEV	and	1,	2,	3,	4,	5	µg/band	EE)	for	HPTLC	method.	
	
Table	4.	Statistical	comparison	between	the	results	obtained	by	the	proposed	methods	and	reported	methods	[8]	for	the	determination	of	LEV	and	EE	in	pure	
powder	form.	
Items	 LEV
RD	 RS	 AM	 AS	 DR	 HPTLC	 Reported	method		
Mean	a	 99.40	 99.90	 99.90 99.40 100.10 99.70 99.40	
RSD%	 1.01 1.14	 0.93 1.38 1.35 1.31 1.01	
SEM	 0.38 0.40	 0.35 0.52 0.51 0.59 0.41	
Variance	 1.01 1.30	 0.87 1.88 1.84 1.72 1.02	
n	 7	 7	 7	 7	 7	 5	 6	
Student´s	t‐test	b,	c	 0.8280	 0.8517	 0.9970	 0.0038	 1.0180	 0.3940	 	
F	value	 1.807	d	 1.281	e	 1.174	d 1.854	e 1.809	e 1.689	f
EE	
Items	 RD	 ‐	 AM	 AS	 DR	 HPTLC	 Reported	method		
Mean	a	 100.10	 ‐	 99.40 99.70 99.90 101.10 99.70	
RSD%	 1.07 ‐	 0.76 0.98 0.97 1.36 0.75	
SEM	 0.40 ‐	 0.29 0.37 0.37 0.62 0.31	
Variance	 1.13 ‐	 0.57 0.95 0.93 1.89 0.56	
n	 7	 ‐	 7 7 7 5 6	
Student´s	t‐test	b,	c	 0.0510	 ‐	 0.7094 0.0080 0.4264 2.1670 	
F	value	 1.128	e	 ‐	 1.661	e	 1.024	e	 1.696	e	 3.382	f	 	
a	Average	of	three	experiments.	
b	The	corresponding	tabulated	value	of	t	equals	to	2.201	at	p	=	0.05	for	the	spectrophotometric	methods.	
c	The	corresponding	tabulated	value	of	t	equals	to	2.2621	at	p	=	0.05	for	the	HPTLC	method.	
d	The	corresponding	tabulated	value	of	F	equals	to	4.39	at	p	=	0.05.		
e	The	corresponding	tabulated	value	of	F	equals	to	4.95	at	p	=	0.05.	
f		The	corresponding	tabulated	value	of	F	equals	to	5.19	at	p	=	0.05.	
	
	
3.3.4.	Selectivity	
	
Selectivity	was	established	by	analyzing	different	mixtures	
of	 the	 drugs	 in	 different	 ratios	 within	 the	 linearity	 range.	
Satisfactory	 results	 were	 shown	 in	 Table	 2.	 Good	 recovery	
percentages	with	accepted	standard	deviations	were	obtained	
in	all	cases.	
	
3.3.5.	Limits	of	detection	and	quantification	(LOD	and	LOQ)	
	
The	LOD	 is	 the	 lowest	 concentration	of	 the	drug	 that	 can	
be	detected,	but	not	necessarily	quantitated,	under	the	stated	
experimental	conditions.	The	LOQ	is	the	lowest	concentration	
of	 the	 analyte	 that	 can	 be	 determined	 with	 acceptable	
precision	 and	 accuracy.	 Both	 LOD	 and	 LOQ	 were	 calculated	
and	the	results	were	abridged	in	Table	1.	
	
3.4.	Application	of	the	proposed	methods	
	
The	 proposed	 procedures	 were	 applied	 for	 the	
determination	of	LEV	and	EE	in	Microcept®	tablets	where	the	
obtained	 recovery	 and	 standard	 deviation	 proved	 no	
interference	from	the	excipients.	The	validity	of	the	proposed	
procedures	 was	 further	 evaluated	 by	 applying	 the	 standard	
addition	technique.	The	results	obtained	were	shown	in	Table	
3.	
	
3.5.	Statistical	analysis	
	
Table	 4	 showed	 statistical	 comparisons	 of	 the	 results	
obtained	 by	 the	 proposed	 methods	 and	 the	 pharmacopoeial	
method	 [8].	 No	 significant	 difference	 between	 the	 proposed	
and			the			reference			method			with		respect			to		accuracy			and		
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Table	5.	One	way	ANOVA	testing	for	the	different	proposed	and	reported	method	[8]	used	for	the	determination	of	LEV	and	EE	*.	
Drug	 Source	of	variation	 DF	 Sum	of	squares	 Mean	square	 F	value	
LEV	 Between	experiment	 6	 7.429 1.2380 0.935	(2.342)	
Within	experiment	 39	 51.663 1.3247
EE	 Between	experiment	 5	 10.91758 2.183516 2.258	(2.502)	
Within	experiment	 33	 31.91307 0.967063
*	The	values	between	parentheses	are	the	theoretical	F	values,	the	population	means	are	not	significantly	different.	
	 	
	
precision	was	ascertained	as	the	calculated	t	and	F	values	were	
less	than	the	theoretical	ones.	One‐way	ANOVA	was	performed	
for	 the	purpose	of	 comparison	of	 developed	methods;	where	
Table	 5	 showed	 no	 significant	 difference	 between	 the	
developed	methods.	
	
4.	Conclusions	
	
This	 work	 introduced	 the	 application	 of	 sensitive,	
selective,	 accurate	and	precise	spectrophotometric	 resolution	
techniques	 and	 HPTLC	 method	 for	 the	 analysis	 of	 binary	
mixtures	of	 levonorgestrel	and	ethinyl	estradiol.	The	spectro‐
photometric	methods	were	dependent	either	on	the	utilization	
of	 the	ratio	spectra	of	 the	drugs	or	 the	presence	of	 isosbestic	
point.	The	advantages	of	each	of	the	developed	spectrophoto‐
metric	methods	were	discussed.	The	HPTLC	(on	Nano	silica	gel	
plates)	method	besides	its	high	sensitivity,	had	the	advantages	
of	being	simple	and	economic	where	up	 to	20	samples	 could	
be	applied	to	a	single	plate	and	analyzed	per	one	development.	
The	 proposed	 methods	 were	 directly	 applied	 for	 the	 multi‐
component	 determination	 in	 laboratory	 prepared	 mixtures	
and	 in	 pharmaceutical	 formulation	without	 the	 need	 for	 any	
priory	chemical	treatment	such	as	derivatization	or	extraction	
and	 with	 minimum	 mathematical	 manipulating	 steps.	 As	 a	
final	 conclusion,	 the	 proposed	 methods	 could	 be	 effectively	
used	 for	 the	 routine	 analysis	 of	 the	 studied	 drugs	 in	 quality	
control	laboratories	with	satisfactory	accuracy	and	precision.		
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